Open AccessPathogenetic substantiation to correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liver diseases and disorders of thyroid homeostasis
Author(s) -
K. A. Chympoy,
N.V. Pashkovska,
О. І. Федів,
N. M. Pavlibroda
Publication year - 2014
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xviii.2.70.2014.84
Subject(s) - fibrinolysis , medicine , homeostasis , blood plasma , pathology , endocrinology
The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases against the ground of administration of “Triovit”, a selenium-containing drug, has been studied. The administration of “Triovit” in a comprehensive therapy of patients with chronic diffuse liver diseases was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma.